Peptide Assemblies for Cancer Therapy

ChemMedChem. 2023 Sep 1;18(17):e202300258. doi: 10.1002/cmdc.202300258. Epub 2023 Jul 20.

Abstract

Supramolecular assemblies made by the self-assembly of peptides are finding an increasing number of applications in various fields. While the early exploration of peptide assemblies centered on tissue engineering or regenerative medicine, the recent development has shown that peptide assemblies can act as supramolecular medicine for cancer therapy. This review covers the progress of applying peptide assemblies for cancer therapy, with the emphasis on the works appeared over the last five years. We start with the introduction of a few seminal works on peptide assemblies, then discuss the combination of peptide assemblies with anticancer drugs. Next, we highlight the use of enzyme-controlled transformation or shapeshifting of peptide assemblies for inhibiting cancer cells and tumors. After that, we provide the outlook for this exciting field that promises new kind of therapeutics for cancer therapy.

Keywords: cancer therapy; enzyme; peptide; self-assembly; supramolecular medicine.

Publication types

  • Review
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • Humans
  • Neoplasms* / drug therapy
  • Peptides / chemistry
  • Peptides / pharmacology
  • Peptides / therapeutic use
  • Tissue Engineering

Substances

  • Peptides
  • Antineoplastic Agents